552c7ae14ClaimThe European Commission opened an antitrust investigation into Sanofi's flu vaccine marketing practicesAgreeDisagree
552c7ae14ClaimTraditional flu vaccine production relies on egg-based manufacturing with a six-month timelineAgreeDisagree
552c7ae14ClaimmRNA platform technology enables faster vaccine development cycles compared to traditional egg-based productionAgreeDisagree
552c7ae14ClaimThe FDA approved Moderna's mFlusiva as the first mRNA-based flu vaccine in the United StatesAgreeDisagree
552c7ae14ClaimThe UK approved the first trial of a Moderna-Oxford mRNA vaccine to prevent Lynch Syndrome cancersAgreeDisagree
552c7ae14ClaimSeasonal flu vaccines may reduce severity of H5N1 bird flu infections in humansAgreeDisagree
552c7ae14ClaimGSK advanced its mRNA flu vaccine to late-stage trials after strong mid-stage resultsAgreeDisagree
552c7ae14ClaimIndia administered 8 million HPV vaccine doses in six months since its national campaign launchAgreeDisagree
552c7ae14ClaimThe Andes hantavirus is the only known strain capable of human-to-human transmissionAgreeDisagree
552c7ae14ClaimThe CDC hantavirus response was inadequate given the severity of the outbreak — debated regarding resource allocation for emerging infectious disease threatsAgreeDisagree
552c7ae14Claim17 Americans from the hantavirus-affected cruise ship arrived in Nebraska for quarantine, with one testing positiveAgreeDisagree
552c7ae14ClaimHantavirus is primarily transmitted through rodent excreta in most known variantsAgreeDisagree
552c7ae14ClaimThe MV Hondius cruise ship docked in Rotterdam for disinfection after the outbreakAgreeDisagree
552c7ae14ClaimThe CDC ended its hantavirus response following the cruise ship outbreak that killed threeAgreeDisagree
552c7ae14ClaimHantavirus cases spread across Europe with a protocol breach at a Dutch hospital and a new case in SpainAgreeDisagree
552c7ae14ClaimThree people died from hantavirus on a cruise ship, with WHO confirming possible human-to-human transmissionAgreeDisagree
552c7ae14ClaimAccelerated vaccine development pathways compromise safety — debated regarding the balance between speed of innovation and thoroughness of regulatory reviewAgreeDisagree